Latest filing published 05 May 2021 for Deciphera Pharmaceuticals, Inc., €18k.
Filing timeline
BuySaleInsider track record
Michael Douglas Taylor: trading record in brief
Michael Douglas Taylor is a declared insider of Deciphera Pharmaceuticals, Inc. (senior executive), with filings sourced from SEC (Form 4). Between 5 February 2019 and 3 May 2021, the trades on record add up to 98 filings.
On the market, this insider has only sold: 68 sales, €30.7M in total. Besides market trades, the filings include 30 option exercises. Since January 2021: no purchases and 13 sales on the market.
The latest filing, published on 5 May 2021, reports an option exercise of €18k in Deciphera Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Michael Douglas Taylor
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,646 shares@ US$3.950.1% of flowCommon StockSEC:0001209191-21-030292:1
- 7,700 shares@ US$46.070.9% of flowCommon StockSEC:0001209191-21-030292:2
- 300 shares@ US$46.750.0% of flowCommon StockSEC:0001209191-21-030292:3
- 2,354 shares@ US$1.89100.0% of flowCommon StockSEC:0001209191-21-030292:0
- 8,000 shares@ US$1.890.0% of flowCommon StockSEC:0001209191-21-025551:0
- 2,100 shares@ US$44.800.3% of flowCommon StockSEC:0001209191-21-025551:1
- 4,994 shares@ US$45.690.6% of flowCommon StockSEC:0001209191-21-025551:2
- 906 shares@ US$46.720.1% of flowCommon StockSEC:0001209191-21-025551:3
- 8,000 shares@ US$1.890.0% of flowCommon StockSEC:0001209191-21-016782:0
- 6,896 shares@ US$43.940.8% of flowCommon StockSEC:0001209191-21-016782:1
- 1,104 shares@ US$44.680.1% of flowCommon StockSEC:0001209191-21-016782:2
- 8,000 shares@ US$1.890.0% of flowCommon StockSEC:0001209191-21-007183:0
- 2,682 shares@ US$44.340.3% of flowCommon StockSEC:0001209191-21-007183:1
- 4,518 shares@ US$45.640.5% of flowCommon StockSEC:0001209191-21-007183:2
- 800 shares@ US$45.960.1% of flowCommon StockSEC:0001209191-21-007183:3
- 19,000 shares@ US$1.890.1% of flowCommon StockSEC:0001209191-21-001982:0
- 7,689 shares@ US$55.801.1% of flowCommon StockSEC:0001209191-21-001982:1
- 8,517 shares@ US$56.731.2% of flowCommon StockSEC:0001209191-21-001982:2
- 2,794 shares@ US$57.370.4% of flowCommon StockSEC:0001209191-21-001982:3
- 19,000 shares@ US$1.890.1% of flowCommon StockSEC:0001209191-20-061466:0
- 6,480 shares@ US$60.23381.2% of flowCommon StockSEC:0001209191-20-061466:1
- 11,309 shares@ US$61.1632.1% of flowCommon StockSEC:0001209191-20-061466:2
- 1,011 shares@ US$61.86630.2% of flowCommon StockSEC:0001209191-20-061466:3
- 200 shares@ US$62.940.0% of flowCommon StockSEC:0001209191-20-061466:4
- 15,000 shares@ US$1.890.1% of flowCommon StockSEC:0001209191-20-057262:0
25 of 98 declarations
